Anorexia nervosa is characterised by a chronic course that is refractory to treatment in many patients and has one of the highest mortality rates of any psychiatric disorder. Deep brain stimulation ( ...

A study has prospectively evaluated consumptions of sweetened beverages, coffee and tea in relation to depression among older US adults. Sweetened beverages, coffee and tea are commonly consumed world ...

Clinicians have long speculated that poor sleep may be a mechanism involved in the higher risk of further cardiac events or death among those with post-traumatic stress disorder ( PTSD ) following an ...

Excess weight and obesity in the general population are increasing problems throughout the Western world, and this rise has also been observed in children and adolescents.Weight gain and obesity are k ...

Varenicline ( Chantix, Champix ), a smoking cessation medication, has been under a cloud of suspicion ever since the Canadian Medical Association Journal ( CMAJ ) published a study July 2011 reporting ...

New data have shown the efficacy of Agomelatine ( Valdoxan ) in the treatment of anxiety in depressed patients when compared with other commonly prescribed antidepressants. Additionally, Valdoxan's an ...

The poor safety profile of the smoking-cessation drug Varenicline ( Chantix, Champix ) makes it unsuitable for first-line use, according to a study published in the journal PLoS One,Varenicline, which ...

Taking newer types of antipsychotic drugs could increase a persons risk of developing dangerous blood clots, according to a new University of Nottingham study published on British Medical Journal.Ven ...

A pilot study has suggested the hallucinogen Psilocybin may be feasible and safe to administer to patients with advanced-stage cancer and anxiety, with promising effects on mood.In recent years, there ...

Naltrexone, a drug commonly used to treat alcohol and drug addiction, has a similar effect on the compulsive behavior of kleptomaniacs; it curbs their urge to steal.Kleptomania is a type of impulse co ...

Asenapine ( Saphris ) met the primary endpoint over one year of treatment in an extension study in patients with predominant, persistent negative symptoms of schizophrenia.Negative symptoms of schizop ...